Cold Allergy And Sinus Tablet Global Market Report 2026
상품코드:1942582
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
한랭 알레르기 및 부비강염 치료제 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 304억 달러에서 2026년에는 320억 달러로, CAGR 5.2%로 확대가 전망되고 있습니다. 지난 수년간의 성장은 알레르기성 비염의 유병률 증가, 계절성 감기의 발생률 증가, 일반 의약품의 광범위한 가용성, 자가 치료 습관의 확대, 확립된 의약품 소매 네트워크에 기인하는 것으로 보입니다.
감기·알레르기·부비강염 치료제 태블릿 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 390억 8,000만 달러에 달하며, CAGR은 5.1%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 도시 지역의 오염 노출 증가, 복합 요법에 대한 소비자 선호도 증가, 알레르기 관리 솔루션에 대한 수요 증가, 온라인 약국 유통 확대, 지속적인 제품 재제형 혁신 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 다증상 복합제에 대한 수요 증가, 졸음이 없는 제형에 대한 선호도 증가, 즉각적인 완화 솔루션에 대한 관심 확대, 연령별 용량의 다양성 확대, 서방형 정제에 대한 강조 강화 등을 꼽을 수 있습니다.
알레르기 및 호흡기 질환의 발생률 증가는 향후 수년간 감기, 알레르기 및 부비동염 치료제 시장의 성장을 촉진할 것으로 예측됩니다. 이러한 질환은 알레르겐에 대한 면역계 반응을 동반하고 호흡기에 영향을 미쳐 천식, 알레르기성 비염과 같은 질환을 유발합니다. 알레르기 및 호흡기 질환의 급증은 주로 대기 오염의 악화와 관련이 있으며, 알레르기 항원 및 공기 중 자극 물질에 대한 노출을 증가시켜 유해한 면역 반응과 호흡기 반응을 유발합니다. 한랭 알레르기 및 부비동염 치료제는 효과적인 증상 완화를 통해 감기, 부비동염, 알레르기 반응으로 고생하는 사람들의 삶의 질을 향상시키는데 도움을 줄 수 있습니다. 예를 들어 2023년 9월 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)는 만성 호흡기 질환으로 인한 사망자 수가 410만 명에 달한다고 보고했습니다. 이는 심혈관 질환(1,790만 명)에 이어 암(930만 명), 당뇨병(200만 명)보다 많은 수치입니다. 이처럼 호흡기 및 알레르기 질환 증가 추세는 감기-알레르기-부비동염 치료제 시장 수요를 견인하고 있습니다.
감기, 알레르기, 부비동염 치료제 시장에서 사업을 운영하는 주요 기업은 치료 편의성 향상, 광범위한 증상 완화, 다중 약물 복용량 감소를 목표로 여러 유효 성분을 단일 정제에 배합한 혁신적인 고정용량 복합제(FDC) 개발에 주력하고 있습니다. FDC 제제는 진통제, 해열제, 비충혈제거제, 항히스타민제 등 상호보완적인 약물을 결합하여 기존 단일 성분 정제 대비 감기, 알레르기, 부비동 증상에 대한 통합적인 완화 효과를 제공합니다. 예를 들어 2025년 4월, 미국에 본사를 둔 제약 및 컨슈머 헬스케어 제품 기업 존슨앤드존슨(Johnson & Johnson)은 감기, 알레르기, 부비동의 불편함을 단기간에 완화하는 '시누맥스 알레르기 부비동 카프렛'을 출시했습니다. 본 캡슐제에는 파라세타몰 500mg, 염산 슈도에페드린 30mg, 클로르페닐라민 말레인산염 2mg이 함유되어 있으며, 코막힘, 두통, 발열, 재채기, 콧물 등의 증상에 대응합니다. 무설탕 필름 코팅, 속효성 제제, 비진정성 항히스타민 성분으로 사용시 편안함과 복용 편의성을 향상시켰습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Cold allergy and sinus tablets are over-the-counter or prescription medications formulated to relieve symptoms related to colds, allergies, and sinus conditions. These tablets typically combine antihistamines, decongestants, and pain relievers to reduce inflammation, congestion, and discomfort caused by these conditions.
The main types of cold allergy and sinus tablets include antihistamines, decongestants, cough suppressants, expectorants, and combination tablets. Antihistamines are medications that block or reduce the effects of histamines, chemicals released by the immune system during allergic reactions. These products are available in various formulations, including tablets, capsules, liquids, effervescent tablets, and powders. The consumer age groups vary from children (0-12 years) to teenagers (13-19 years), adults (20-64 years), and seniors (65 years and above). These products address multiple conditions, such as allergic rhinitis, the common cold, sinusitis, and more. Distribution occurs through several channels, including pharmacies, online stores, supermarkets or hypermarkets, and others.
Tariffs are impacting the cold allergy and sinus tablet market by increasing the cost of imported active pharmaceutical ingredients, excipients, packaging materials, and specialized manufacturing inputs used in antihistamines, decongestants, and combination tablets. North America and Europe are particularly affected due to dependence on imported APIs from Asia-Pacific manufacturing hubs such as China and India. These tariffs are contributing to higher production costs and pricing pressures for branded and generic products. However, they are also encouraging local API manufacturing, diversification of sourcing strategies, and increased investments in domestic pharmaceutical production capabilities.
The cold allergy and sinus tablet market research report is one of a series of new reports from The Business Research Company that provides cold allergy and sinus tablet market statistics, including cold allergy and sinus tablet industry global market size, regional shares, competitors with a cold allergy and sinus tablet market share, detailed cold allergy and sinus tablet market segments, market trends and opportunities, and any further data you may need to thrive in the cold allergy and sinus tablet industry. This cold allergy and sinus tablet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cold allergy and sinus tablet market size has grown strongly in recent years. It will grow from $30.4 billion in 2025 to $32 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to rising prevalence of allergic rhinitis, increased seasonal cold incidences, widespread availability of OTC medications, growth of self-medication practices, established pharmaceutical retail networks.
The cold allergy and sinus tablet market size is expected to see strong growth in the next few years. It will grow to $39.08 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to growing urban pollution exposure, increasing consumer preference for combination therapies, rising demand for allergy management solutions, expansion of online pharmacy distribution, continuous product reformulation innovation. Major trends in the forecast period include increasing demand for multi-symptom combination tablets, rising preference for non-drowsy formulations, growing focus on fast-acting relief solutions, expansion of age-specific dosage variants, enhanced emphasis on extended-release tablets.
The increasing incidence of allergies and respiratory disorders is projected to drive growth in the cold allergy and sinus tablet market in the years ahead. These conditions involve immune system responses to allergens and affect the respiratory system, leading to illnesses such as asthma and allergic rhinitis. The surge in allergies and respiratory issues is largely linked to rising air pollution, which heightens exposure to allergens and airborne irritants that trigger adverse immune and respiratory reactions. Cold allergy and sinus tablets assist in managing these conditions by providing effective symptom relief, thereby enhancing the quality of life for individuals suffering from colds, sinus infections, and allergic reactions. For example, in September 2023, the World Health Organization, an intergovernmental agency based in Switzerland, reported that chronic respiratory diseases were responsible for 4.1 million deaths, ranking behind cardiovascular disease (17.9 million deaths) and cancer (9.3 million deaths), and ahead of diabetes (2.0 million deaths). Thus, the rising prevalence of respiratory and allergic conditions is fueling demand in the cold allergy and sinus tablet market.
Major companies operating in the cold, allergy, and sinus tablet market are focusing on developing innovative fixed-dose combination (FDC) formulations that incorporate multiple active ingredients into a single tablet to enhance treatment convenience, provide broader symptom relief, and reduce the need for multiple medications. An FDC combines complementary agents-such as an analgesic or antipyretic, a nasal decongestant, and an antihistamine-to deliver integrated relief for cold, allergy, and sinus symptoms compared with traditional single-ingredient tablets. For example, in April 2025, Johnson & Johnson, a U.S.-based pharmaceutical and consumer health products company, launched Sinumax Allergy Sinus Caplets for short-term relief of cold, allergy, and sinus discomfort. The caplets contain paracetamol 500 mg, pseudoephedrine hydrochloride 30 mg, and chlorphenamine maleate 2 mg, addressing nasal congestion, headache, fever, sneezing, and runny nose. Its sugar-free film coating, immediate-release formulation, and non-sedating antihistamine component enhance user comfort and ease of administration.
In April 2025, Clayton, Dubilier & Rice (CD&R), a U.S.-based private equity firm, acquired a 50% controlling stake in Opella from Sanofi S.A. for an undisclosed amount. This transaction aligns with Sanofi's strategy to concentrate on its core innovative medicines and vaccines portfolio while allowing Opella to operate as an independent global consumer health leader with increased investment and growth potential. Opella is a France-based company that manufactures over-the-counter (OTC) products, including cold, allergy, pain relief, digestive health, and wellness brands.
Major companies operating in the cold allergy and sinus tablet market are Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz Group AG, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals plc, Lupin Ltd., Glenmark Pharmaceuticals Ltd., LETI Pharma GmbH, Pfizer Inc., Novartis AG, Haleon Group plc, Perrigo Consumer Healthcare, Zydus Lifesciences Ltd.
North America was the largest region in the cold allergy and sinus tablet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cold allergy and sinus tablet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cold allergy and sinus tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cold allergy and sinus tablet market consists of sales of allerhin cold tablet, sinarest tablet, and allergix cold care tablet. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cold Allergy And Sinus Tablet Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cold allergy and sinus tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cold allergy and sinus tablet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cold allergy and sinus tablet market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Demand For Multi-Symptom Combination Tablets
4.2.2 Rising Preference For Non-Drowsy Formulations
4.2.3 Growing Focus On Fast-Acting Relief Solutions
4.2.4 Expansion Of Age-Specific Dosage Variants
4.2.5 Enhanced Emphasis On Extended-Release Tablets
5. Cold Allergy And Sinus Tablet Market Analysis Of End Use Industries
5.1 Patients With Allergies
5.2 Cold And Sinus Patients
5.3 Elderly Population
5.4 Pediatric Patients
5.5 Healthcare Consumers
6. Cold Allergy And Sinus Tablet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Cold Allergy And Sinus Tablet Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Cold Allergy And Sinus Tablet PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Cold Allergy And Sinus Tablet Market Size, Comparisons And Growth Rate Analysis
7.3. Global Cold Allergy And Sinus Tablet Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Cold Allergy And Sinus Tablet Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Cold Allergy And Sinus Tablet Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Cold Allergy And Sinus Tablet Market Segmentation
9.1. Global Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Children (0-12 years), Teenagers (13-19 years), Adults (20-64 years), Seniors (65 years and above)
9.4. Global Cold Allergy And Sinus Tablet Market, Segmentation By Application Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Allergic Rhinitis, Common Cold, Sinusitis, Upper Respiratory Tract Infections
9.5. Global Cold Allergy And Sinus Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmacies, Online Stores, Supermarkets Or Hypermarkets, Other Distribution Channels
9.6. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pseudoephedrine, Phenylephrine, Oxymetazoline
9.8. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Cough Suppressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Dextromethorphan, Codeine, Benzonatate
9.9. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Guaifenesin, Ammonium Chloride
9.10. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Combination Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Antihistamine-Decongestant Combos, Antihistamine-Cough Suppressant Combos, Multi-Symptom Cold And Flu Tablets
10. Cold Allergy And Sinus Tablet Market Regional And Country Analysis
10.1. Global Cold Allergy And Sinus Tablet Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Cold Allergy And Sinus Tablet Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Cold Allergy And Sinus Tablet Market
11.1. Asia-Pacific Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Cold Allergy And Sinus Tablet Market
12.1. China Cold Allergy And Sinus Tablet Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Cold Allergy And Sinus Tablet Market
13.1. India Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Cold Allergy And Sinus Tablet Market
14.1. Japan Cold Allergy And Sinus Tablet Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Cold Allergy And Sinus Tablet Market
15.1. Australia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Cold Allergy And Sinus Tablet Market
16.1. Indonesia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Cold Allergy And Sinus Tablet Market
17.1. South Korea Cold Allergy And Sinus Tablet Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Cold Allergy And Sinus Tablet Market
18.1. Taiwan Cold Allergy And Sinus Tablet Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Cold Allergy And Sinus Tablet Market
19.1. South East Asia Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Cold Allergy And Sinus Tablet Market
20.1. Western Europe Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Cold Allergy And Sinus Tablet Market
21.1. UK Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Cold Allergy And Sinus Tablet Market
22.1. Germany Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Cold Allergy And Sinus Tablet Market
23.1. France Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Cold Allergy And Sinus Tablet Market
24.1. Italy Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Cold Allergy And Sinus Tablet Market
25.1. Spain Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Cold Allergy And Sinus Tablet Market
26.1. Eastern Europe Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Cold Allergy And Sinus Tablet Market
27.1. Russia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Cold Allergy And Sinus Tablet Market
28.1. North America Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Cold Allergy And Sinus Tablet Market
29.1. USA Cold Allergy And Sinus Tablet Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Cold Allergy And Sinus Tablet Market
30.1. Canada Cold Allergy And Sinus Tablet Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Cold Allergy And Sinus Tablet Market
31.1. South America Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Cold Allergy And Sinus Tablet Market
32.1. Brazil Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Cold Allergy And Sinus Tablet Market
33.1. Middle East Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Cold Allergy And Sinus Tablet Market
34.1. Africa Cold Allergy And Sinus Tablet Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Segmentation By Formulation Type, Segmentation By Consumer Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Cold Allergy And Sinus Tablet Market Regulatory and Investment Landscape
36. Cold Allergy And Sinus Tablet Market Competitive Landscape And Company Profiles
36.1. Cold Allergy And Sinus Tablet Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Cold Allergy And Sinus Tablet Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Cold Allergy And Sinus Tablet Market Company Profiles
36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
37. Cold Allergy And Sinus Tablet Market Other Major And Innovative Companies
Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz Group AG, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals plc, Lupin Ltd., Glenmark Pharmaceuticals Ltd., LETI Pharma GmbH, Pfizer Inc., Novartis AG, Haleon Group plc
38. Global Cold Allergy And Sinus Tablet Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Cold Allergy And Sinus Tablet Market
40. Cold Allergy And Sinus Tablet Market High Potential Countries, Segments and Strategies
40.1 Cold Allergy And Sinus Tablet Market In 2030 - Countries Offering Most New Opportunities
40.2 Cold Allergy And Sinus Tablet Market In 2030 - Segments Offering Most New Opportunities
40.3 Cold Allergy And Sinus Tablet Market In 2030 - Growth Strategies
